ProKidney Corp. (PROK) Revenue Growth
ProKidney Corp. (PROK) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | N/A |
| 2025-12-31 | 1075.00% |
How PROK compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | 370.22% |
| TXMD | TherapeuticsMD Inc. | 71.61% |
| RIGL | Rigel Pharmaceuticals Inc. | 64.15% |
| AKBA | Akebia Therapeutics Inc. | 47.46% |
| RFL | Rafael Holdings Inc. Class B | 43.96% |
These are five companies in the same sector as PROK with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get ProKidney Corp. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("PROK", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PROK | $1.46 | -1.02% | 0.51M |
| 3 | ||||
| 4 | ||||
| 5 |